We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$318B
AUM Growth
+$7.42B
Cap. Flow
+$12.8B
Cap. Flow %
4.02%
Top 10 Hldgs %
13.83%
Holding
10,865
New
1,329
Increased
3,996
Reduced
3,901
Closed
1,130

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$541M
2
MSFT icon
Microsoft
MSFT
+$517M
3
META icon
Meta Platforms (Facebook)
META
+$493M
4
WTW icon
Willis Towers Watson
WTW
+$405M
5
AMZN icon
Amazon
AMZN
+$372M

Sector Composition

Rank Sector Weight
1 Technology 12.18%
2 Financials 7.26%
3 Consumer Discretionary 6.08%
4 Healthcare 6.04%
5 Communication Services 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSIBW
9326
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$1K ﹤0.01%
937
+537
+134% +$539
PHIC
9327
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
$1K ﹤0.01%
72
-253
-78% -$2.48K
PHICW
9328
DELISTED
Population Health Investment Co., Inc. Warrant
PHICW
$1K ﹤0.01%
+941
New +$877
WPCB.WS
9329
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$1K ﹤0.01%
1,300
+600
+86% +$705
ACEVU
9330
DELISTED
ACE Convergence Acquisition Corp
ACEVU
$1K ﹤0.01%
+51
New +$520
EPWR.WS
9331
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$1K ﹤0.01%
1,444
+602
+71% +$404
FSRDW
9332
DELISTED
Fast Radius, Inc. Warrants
FSRDW
$1K ﹤0.01%
+880
New +$872
LHC.WS
9333
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$1K ﹤0.01%
1,464
-589
-29% -$458
MITO
9334
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$1K ﹤0.01%
487
-14,820
-97% -$20.1K
NSTC.WS
9335
DELISTED
Northern Star Investment Corp. III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTC.WS
$1K ﹤0.01%
997
+597
+149% +$700
AMPI.WS
9336
DELISTED
Advanced Merger Partners Inc Warrants
AMPI.WS
$1K ﹤0.01%
1,283
+933
+267% +$960
USWSW
9337
DELISTED
U.S. Well Services, Inc. Warrants
USWSW
$1K ﹤0.01%
5,825
-5,147
-47% -$730
CLIM.WS
9338
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$1K ﹤0.01%
+592
New +$693
PAQCW
9339
DELISTED
Provident Acquisition Corp. Warrant
PAQCW
$1K ﹤0.01%
+2,420
New +$1.78K
REC
9340
DELISTED
Emles Real Estate Credit ETF
REC
$1K ﹤0.01%
+50
New +$1.25K
FVT.WS
9341
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$1K ﹤0.01%
1,165
-2,109
-64% -$2.31K
AVAN
9342
DELISTED
Avanti Acquisition Corp.
AVAN
$1K ﹤0.01%
63
-5,018
-99% -$48.9K
DTOX
9343
DELISTED
Amplify Cleaner Living ETF
DTOX
$1K ﹤0.01%
+26
New +$617
NMMCW
9344
DELISTED
North Mountain Merger Corp. Warrant
NMMCW
$1K ﹤0.01%
1,295
-3,682
-74% -$3.29K
SLCRW
9345
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$1K ﹤0.01%
2,167
-4,547
-68% -$3.24K
CLAQR
9346
DELISTED
CleanTech Acquisition Corp. Rights
CLAQR
$1K ﹤0.01%
+6,095
New +$1.31K
ALJJ
9347
DELISTED
ALJ Regional Holdings Inc
ALJJ
$1K ﹤0.01%
1,174
-4,036
-77% -$5.18K
JMIN
9348
DELISTED
JPMorgan U.S. Minimum Volatility ETF
JMIN
$1K ﹤0.01%
42
-115
-73% -$4.15K
ETACW
9349
DELISTED
E.Merge Technology Acquisition Corp. Warrant
ETACW
$1K ﹤0.01%
+1,992
New +$1.65K
ACKIW
9350
DELISTED
Ackrell SPAC Partners I Co Warrants
ACKIW
$1K ﹤0.01%
1,848
+1,596
+633% +$899

Similar funds

UBS Group's Q3 2021 Portfolio in Review

As of Q3 2021, UBS Group held 10,865 positions worth $318B, up 2.4% from $310B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $12.8B of net new capital in Q3 2021, opening 1,329 new positions and adding to 3,996 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 1,947,829 shares worth $50.4M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $626M trimmed.

  • UBS Group's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 1,947,829 shares worth $50.4M.
  • UBS Group added most to Apple in Q3 2021, an estimated $541M increase.
  • UBS Group's biggest Q3 2021 reduction was Invesco QQQ Trust, cutting an estimated $626M.
  • UBS Group fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $282M.
  • UBS Group's ten largest holdings make up 14% of its $318B portfolio in Q3 2021.
  • UBS Group opened 1,329 new positions and closed 1,130 in Q3 2021.
  • UBS Group's portfolio value rose 2.4% quarter-over-quarter to $318B.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.